| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.421 | 17.875 | 19.543 | 20.803 | 21.034 | 19.589 | 22.627 | 20.878 | 19.167 | 24.545 |
| Total Income - EUR | 16.498 | 17.938 | 19.567 | 20.829 | 21.088 | 20.214 | 22.665 | 20.912 | 19.219 | 24.759 |
| Total Expenses - EUR | 15.719 | 17.603 | 18.951 | 20.122 | 20.856 | 20.437 | 20.935 | 20.613 | 18.931 | 24.017 |
| Gross Profit/Loss - EUR | 780 | 335 | 616 | 707 | 232 | -223 | 1.730 | 300 | 288 | 742 |
| Net Profit/Loss - EUR | 285 | 156 | 421 | 501 | 21 | -346 | 1.629 | 121 | 115 | 67 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 1 |
Check the financial reports for the company - Polimed Petrosani S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.708 | 3.181 | 2.997 | 2.456 | 1.932 | 1.428 | 939 | 483 | 58 | 12 |
| Current Assets | 5.319 | 5.691 | 6.197 | 7.234 | 6.606 | 6.671 | 8.317 | 8.895 | 9.294 | 9.158 |
| Inventories | 0 | 79 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 232 | 989 | 165 | 583 |
| Cash | 5.319 | 5.611 | 6.197 | 7.234 | 6.606 | 6.671 | 8.084 | 7.906 | 9.130 | 8.575 |
| Shareholders Funds | 8.063 | 7.855 | 8.143 | 8.494 | 7.307 | 6.822 | 8.300 | 8.446 | 8.535 | 8.555 |
| Social Capital | 940 | 931 | 915 | 898 | 881 | 864 | 845 | 848 | 845 | 840 |
| Debts | 964 | 1.017 | 1.052 | 1.196 | 1.231 | 1.276 | 956 | 932 | 818 | 615 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Polimed Petrosani S.r.l.